Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer

被引：47
|
作者：
Matsuyama, W
Nakagawa, M
Wakimoto, J
Hirotsu, Y
Kawabata, M
Osame, M
机构：
[1] Kagoshima Univ, Fac Med, Dept Internal Med 3, Kagoshima 8908520, Japan
[2] Natl Minami Kyushu Hosp, Dept Pathol, Kagoshima, Japan
[3] Natl Minami Kyushu Hosp, Dept Thorac Surg, Kagoshima, Japan
来源：
HUMAN MUTATION | 2003年 / 21卷 / 04期
关键词：
D O I：
10.1002/humu.10196
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
下载
收藏
页码：441 / 443
页数：3
相关论文
共 50 条
  • [21] DNA content in correlation with postsurgical stage in non-small cell lung cancer
    Hofmann, HS
    Neef, H
    Knolle, J
    Beckhausen, E
    Beyer, U
    Klapperstuck, T
    Lautenschlager, C
    Zerkowski, HR
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1067 - 1067
  • [22] EGFR mutation detection in plasma cell-free DNA correlates with clinical outcomes in non-small cell lung cancer
    Shi, J.
    Mong, J.
    Chin, T. M.
    Lim, Y. H.
    Tan, W. L.
    Toh, C. K.
    Tan, H. S.
    Wong, S-W.
    Tee, A.
    Chan, D.
    Wong, K.
    Yeap, S.
    Ngo, L.
    Tan, Y-O.
    Tan, M-H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Mitochondrial Dynamics in Non-Small Cell Lung Cancer
    Dutkowska, Agata
    Domanska-Senderowska, Daria
    Czarnecka-Chrebelska, Karolina H.
    Pikus, Ewa
    Zielinska, Aleksandra
    Biskup, Laura
    Kolodziejska, Agata
    Madura, Paulina
    Mozdzan, Maria
    Zaluska, Urszula
    Zheng, Edward
    Adamczyk, Eliza
    Kedzia, Konrad
    Wcislo, Szymon
    Wawrzycki, Marcin
    Brzezianska-Lasota, Ewa
    Jablonski, Slawomir
    Antczak, Adam
    Poznanski, Michal
    CANCERS, 2024, 16 (16)
  • [24] The effect of alcoholism on the prognosis of stage III and IV non-small cell lung cancer
    Paull, DE
    Updyke, GM
    Pacheco, J
    Chin, HW
    Baumann, M
    Adebonojo, SA
    CHEST, 2004, 126 (04) : 769S - 770S
  • [25] PROGNOSIS FACTORS IN PATHOLOGIC STAGE I NON-SMALL CELL LUNG CANCER IN CHINA
    Pei, J.
    Han, B.
    RESPIROLOGY, 2011, 16 : 186 - 186
  • [26] MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)
    Yip, Po Yee
    Cooper, Wendy
    Mahar, Annabelle
    Kench, James
    Kohonen-Corish, Maija R. J.
    Chatfield, Mark
    Boulghourjian, Alice
    Kennedy, Catherine W.
    Mccaughan, Brian
    Boyer, Michael
    Horvath, Lisa
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S499 - S499
  • [27] Stage III Non-small Cell Lung Cancer
    Rusch, Valerie W.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (05) : 727 - 735
  • [28] MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer
    Yuan, Kehua
    Chen, Zhigang
    Li, Wenhui
    Gao, Chang E.
    Li, Gaofeng
    Guo, Gang
    Yang, Yi
    Ai, Yiqin
    Wu, Lu
    Zhang, Ming
    ARCHIVES OF MEDICAL RESEARCH, 2015, 46 (08) : 635 - 641
  • [29] CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis
    Dong, Qian-Ze
    Wang, Yang
    Dong, Xin-Jun
    Li, Zi-Xuan
    Tang, Zhong-Ping
    Cui, Quan-Ze
    Wang, En-Hua
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (03) : 857 - 865
  • [30] MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer
    Wang, Yu-zhou
    Wu, Kun-peng
    Wu, Ai-bing
    Yang, Zhi-cheng
    Li, Jin-mei
    Mo, Yan-li
    Xu, Meng
    Wu, Bin
    Yang, Zhi-xiong
    TUMOR BIOLOGY, 2014, 35 (10) : 9815 - 9821
12345